PneumoWave

PneumoWave

Powering the future diagnosis, monitoring and treatment of respiratory illness.

  • Edit

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
USD20222023
Revenues00000000
% growth-110 %
EBITDA00000000
Profit00000000
EV00000000
EV / revenue00.0x00.0x
EV / EBITDA00.0x00.0x
R&D budget00000000

Source: Dealroom estimates

More about PneumoWave
Made with AI
Edit

PneumoWave operates in the healthcare sector, focusing on the diagnosis, monitoring, and treatment of respiratory illnesses. The company provides an advanced respiratory monitoring platform that integrates longitudinal patient data, biomarkers, machine learning, and data science. This end-to-end solution offers real-time physiological data and patient-centric biomarkers, enabling clinicians, researchers, and patients to predict, monitor, detect, and alert to respiratory adverse events both in hospitals and at home. PneumoWave's business model leverages these insights to aid in the discovery and development of novel treatments with enhanced therapeutic potential and safety. By unlocking multiple business models, the company serves a diverse clientele, including healthcare providers, researchers, and patients, aiming to improve efficiency and outcomes in respiratory care. Keywords: respiratory, monitoring, AI-driven, biomarkers, patient data, healthcare, treatment, real-time, physiological, safety.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads